By The AustralaSian COVID-19 Trial (ASCOT) has pinpointed the most efficient level of blood thinning treatment needed for patients hospitalized with COVID-19, in a study published in the New England Journal of Medicine Evidence and presented at the American Society for Hematology conference today.
Study reveals recommended anticoagulant therapy for COVID patients
Close Up Scientist using microscope in laboratory room while making medical testing and research
Comments